Ftse Mib
34.714,36
1,09%
DAX
18.778,75
0,53%
S&P 500
5.236,68
0,43%
NASDAQ
16.400,33
0,33%
Bitcoin
62.966,40
-0,13%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IN8bio Inc (INAB) IN8bio Inc (INAB) Notizie

IN8bio Inc

INAB
1,00
-0,01 (-0,99%)
Ultimo aggiornamento: 15:30:15
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:04EDGAR2Form 8-K - Current report
09/5/202422:00GLOBEIN8bio Reports First Quarter 2024 Financial Results and..
07/5/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/4/202412:05GLOBEIN8bio Doses First Patient in Phase 2 Clinical Trial of..
24/4/202414:00GLOBEIN8bio Announces Oral Presentation at the Upcoming American..
16/4/202422:05GLOBEIN8bio to Present at Noble Capital Markets Emerging Growth..
09/4/202422:30GLOBEIN8bio Announces New Preclinical Data for Gamma-Delta..
14/3/202421:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
05/3/202422:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
26/2/202414:00BWIN8bio to Present at Upcoming Investor Conferences
14/2/202414:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
08/2/202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
19/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
18/1/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/1/202423:16EDGAR2Form S-3 - Registration statement under Securities Act of..
04/1/202414:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
15/12/202322:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/12/202314:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202314:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202312:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/12/202312:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202323:15EDGAR2Form 8-K - Current report
11/12/202322:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
11/12/202315:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
11/12/202314:56EDGAR2Form 8-K - Current report
08/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202322:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/12/202322:15EDGAR2Form 8-K - Current report
07/12/202314:00GLOBEIN8bio Appoints Dr. Corinne Epperly to Board of Directors
05/12/202314:00GLOBEIN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
20/11/202315:04EDGAR2Form 8-K - Current report
20/11/202313:00GLOBEIN8bio’s INB-200 Demonstrates Extended Progression-Free..
10/11/202313:00GLOBEIN8bio to Present Data Highlighting Potential of INB-200 and..
09/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:03EDGAR2Form 8-K - Current report
09/11/202322:00GLOBEIN8bio Reports Third Quarter 2023 Financial Results and..
06/11/202314:00GLOBEIN8bio Presents Biologic Correlative Data from the INB-200..
03/11/202317:00GLOBEIN8bio Presents Positive Data Update from Induced..
Apertura: 1,00 Min: 1,00 Max: 1,00
Chiusura: 1,01

La tua Cronologia

NASDAQ
INAB
IN8bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network